Cargando…

Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS

The fatal disease amyotrophic lateral sclerosis (ALS) is characterized by the loss of somatic motor neurons leading to muscle wasting and paralysis. However, motor neurons in the oculomotor nucleus, controlling eye movement, are for unknown reasons spared. We found that insulin-like growth factor 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allodi, Ilary, Comley, Laura, Nichterwitz, Susanne, Nizzardo, Monica, Simone, Chiara, Benitez, Julio Aguila, Cao, Ming, Corti, Stefania, Hedlund, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867585/ https://www.ncbi.nlm.nih.gov/pubmed/27180807 http://dx.doi.org/10.1038/srep25960

Ejemplares similares

LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophy
por: Nichterwitz, Susanne, et al.
Publicado: (2020)

Modeling Motor Neuron Resilience in ALS Using Stem Cells
por: Allodi, Ilary, et al.
Publicado: (2019)

Synaptotagmin 13 is neuroprotective across motor neuron diseases
por: Nizzardo, M., et al.
Publicado: (2020)

Directed midbrain and spinal cord neurogenesis from pluripotent stem cells to model development and disease in a dish
por: Allodi, Ilary, et al.
Publicado: (2014)

Neurturin is a PGC-1α1-controlled myokine that promotes motor neuron recruitment and neuromuscular junction formation
por: Mills, Richard, et al.
Publicado: (2017)

Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis
por: Nijssen, Jik, et al.
Publicado: (2017)

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
por: Rizzo, Federica, et al.
Publicado: (2013)

Neural circuit and synaptic dysfunctions in ALS-FTD pathology
por: Mora, Santiago, et al.
Publicado: (2023)

Laser capture microscopy coupled with Smart-seq2 for precise spatial transcriptomic profiling
por: Nichterwitz, Susanne, et al.
Publicado: (2016)

Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson’s Disease
por: Aguila, Julio, et al.
Publicado: (2021)

Locomotor deficits in a mouse model of ALS are paralleled by loss of V1-interneuron connections onto fast motor neurons
por: Allodi, Ilary, et al.
Publicado: (2021)

Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives
por: Faravelli, Irene, et al.
Publicado: (2014)

Cross‐disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology
por: Comley, Laura H., et al.
Publicado: (2015)

MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors
por: Rizzuti, Mafalda, et al.
Publicado: (2018)

Cellular Programming and Reprogramming: Sculpting Cell Fate for the Production of Dopamine Neurons for Cell Therapy
por: Aguila, Julio C., et al.
Publicado: (2012)

Axon-Seq Decodes the Motor Axon Transcriptome and Its Modulation in Response to ALS
por: Nijssen, Jik, et al.
Publicado: (2018)

Direct Reprogramming of Resident NG2 Glia into Neurons with Properties of Fast-Spiking Parvalbumin-Containing Interneurons
por: Pereira, Maria, et al.
Publicado: (2017)

iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease Development
por: Faravelli, Irene, et al.
Publicado: (2014)

Direct reprogramming of human astrocytes into neural stem cells and neurons
por: Corti, Stefania, et al.
Publicado: (2012)

The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis
por: Schweingruber, Christoph, et al.
Publicado: (2022)

Mouse models of SMA show divergent patterns of neuronal vulnerability and resilience
por: Woschitz, Victoria, et al.
Publicado: (2022)

Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
por: Contardo, Matilde, et al.
Publicado: (2022)

Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)
por: Zanetta, Chiara, et al.
Publicado: (2014)

Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
por: Nizzardo, Monica, et al.
Publicado: (2015)

Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy
por: Ramirez, Agnese, et al.
Publicado: (2018)

Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
por: Gagliardi, Delia, et al.
Publicado: (2022)

iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
por: Simone, Chiara, et al.
Publicado: (2014)

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model
por: Nizzardo, Monica, et al.
Publicado: (2014)

The Electrophysiological Determinants of Corticospinal Motor Neuron Vulnerability in ALS
por: Jara, Javier H., et al.
Publicado: (2020)

Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
por: Saladini, Matteo, et al.
Publicado: (2019)

CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells
por: Reber, Stefan, et al.
Publicado: (2018)

Multi-phaseted problems of TDP-43 in selective neuronal vulnerability in ALS
por: Asakawa, Kazuhide, et al.
Publicado: (2021)

Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin
por: Rizzo, Federica, et al.
Publicado: (2017)

Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
por: Nizzardo, Monica, et al.
Publicado: (2015)

Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability
por: Leal, Sónia S., et al.
Publicado: (2015)

Animal Models of CMT2A: State-of-art and Therapeutic Implications
por: De Gioia, Roberta, et al.
Publicado: (2020)

Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model
por: Dobrowolny, Gabriella, et al.
Publicado: (2005)

α CAR IGF‐1 vector targeting of motor neurons ameliorates disease progression in ALS mice
por: Eleftheriadou, Ioanna, et al.
Publicado: (2016)

Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
por: Rizzo, Federica, et al.
Publicado: (2019)

Macrophage migration inhibitory factor as a component of selective vulnerability of motor neurons in ALS
por: Abu-Hamad, Salah, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e3hoksm1onl7dkk4boshdcftvv